QC
VTRS icon

Quantessence Capital’s Viatris VTRS Stock Holding History

Quantessence Capital’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,858
Closed -$177K – 165
2025
Q3 		$177K Sell
17,858
-170,011
-90% -$1.65M 0.06% 163
2025
Q2 		$1.68M Buy
+187,869
New +$1.59M 0.49% 40

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantessence Capital's VTRS Position: Q4 2025 in Review

Quantessence Capital sold out of Viatris (VTRS) in Q4 2025, closing a stake of 17,858 shares — an estimated $177K sold.

Quantessence Capital first reported a position in VTRS in Q2 2025 and held it in 2 quarters. The position peaked at $1.68M in Q2 2025. 1,005 funds tracked by Wall St. Rank hold VTRS as of Q4 2025.

  • Quantessence Capital reported no remaining Viatris position as of Q4 2025 after selling out during the quarter.
  • Quantessence Capital sold 17,858 Viatris shares in Q4 2025, an estimated $177K.
  • Quantessence Capital first reported a position in Viatris in Q2 2025 and held it in 2 quarters.
  • Quantessence Capital's Viatris position peaked at $1.68M in Q2 2025.
  • 1,005 funds tracked by Wall St. Rank held Viatris as of Q4 2025.

Based on Quantessence Capital's 13F filing for Q4 2025, filed 17 Feb 2026.